BibTex RIS Cite

Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz

Year 2015, Volume: 5 Issue: 3, 155 - 158, 11.12.2015

Ali Tamer , Oğuz Karabay Ahmet Genç

Abstract

Trombositoz tombosit sayısının 400.000/mm3 üzerinde olması olarak tanımlanır. İlaçlar sekonder trombositoz (ST) etyolojisinde yer almaktadır. Bu sunumda siprofloksasin tedavisi sırasında ekstrem trombositoz gelişen 23 yaşındaki bayan olguyu sunmayı amaçladık.

Keywords

Trombositoz Siprofloksasin

References

  • Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
  • Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
  • Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
  • Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
  • Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
  • Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
  • Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
  • Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
  • Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
  • Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
  • Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
  • -
  • Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.

Year 2015, Volume: 5 Issue: 3, 155 - 158, 11.12.2015

Ali Tamer , Oğuz Karabay Ahmet Genç

Abstract

References

  • Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
  • Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
  • Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
  • Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
  • Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
  • Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
  • Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
  • Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
  • Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
  • Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
  • Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
  • -
  • Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.
There are 13 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Ali Tamer

Oğuz Karabay This is me

Ahmet Genç This is me

Publication Date December 11, 2015
Submission Date December 6, 2015
Published in Issue Year 2015 Volume: 5 Issue: 3

Cite

AMA Tamer A, Karabay O, Genç A. Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Tıp Dergisi. December 2015;5(3):155-158.
 Download Cover Image

30703

The published articles in SMJ are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.